Clinical trial
Benefits of a Long Term Implantable Continuous Glucose Monitoring System for Adults With Diabetes - France Randomized Clinical Trial
NCT03445065 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Benefits of a Long Term Implantable Continuous Glucose Monitoring System for Adults With Diabetes - France Randomized Clinical Trial
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2018
- Completion date
- August 20, 2020
- Enrollment
- 239 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.